Nanologica Investor Relations Material
Access more data
Nanologica AB, a nanotechnology company, develops nanoporous silica for applications in the life science industry. Its technology combines a biologically active component with nano-sized pores to improve the delivery of drugs and vaccines to the target via controlled release mechanisms. The company’s products include Nano-pillars and Nano-spheres that are used in various applications such as biological treatments, diagnostics, or therapeutic medicines, as well as drug formulations in pharmaceuticals and other industries. Nanologica AB was founded in 2004 and is based in Södertälje, Sweden.
Klarna's Potential 2024 IPO: From Sequoia to Wall Street
Explore Klarna's journey from a 2005 startup to a fintech giant, its innovative business model, and the anticipation surrounding its 2024 IPO.
23 Feb 2024
Edward "Ted" Decker's Rise to the Top at Home Depot
Explore Ted Decker's transformative impact on Home Depot, including his leadership in retail innovation and strategic vision alongside Craig Menear.
15 Feb 2024
Andy Jassy: Amazon CEO & Pioneer of Cloud Computing
Discover Andy Jassy's remarkable achievements at Amazon, including the creation of Amazon Web Services and his experiences working with Jeff Bezos.
15 Feb 2024